Skip to content

Information About a Doctor or a Possibility of Choosing Doctor's Gender and Attendance to Screening Colonoscopy

Is the Information About a Doctor or Possibility of Choosing Doctor's Gender Associated With Attendance to Screening Colonoscopy: Randomized Study With Three Types of Invitations.

Status
Completed
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01182922
Enrollment
5100
Registered
2010-08-17
Start date
2010-08-31
Completion date
2011-08-31
Last updated
2011-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer, Screening

Keywords

Attendance, Colorectal cancer, Screening, Invitation letter

Brief summary

The purpose of the study is to investigate whether the information about a doctor or possibility to choose doctor's gender included in invitation letter is associated with attendance rate to screening colonoscopy.

Detailed description

Study is performed as a part of NordICC (Clinical trials NCT 00883792) trial, which is intended to investigate the effect of screening colonoscopy on colorectal cancer incidence and mortality. NordICC trial is a multicenter, randomized study conducted in Norway, Sweden, Netherlands and Poland. This study is designed to assess two factors potentially influencing patients attendance. These two factors are: identification of particular doctor performing examination and the possibility of choosing doctor's gender.

Interventions

Invitation letter sent 6 weeks prior to prespecified screening colonoscopy appointment date and followed by reminder letter within 3 weeks if no response is received.

Sponsors

Maria Sklodowska-Curie National Research Institute of Oncology
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
55 Years to 64 Years
Healthy volunteers
No

Inclusion criteria

* Individuals 55-64 years of age randomized to the screening arm of the NordICC trial in Poland

Exclusion criteria

* previous open colorectal surgery * need for long term attention and nursing services (somatic or psychosocial reasons, mental retardation) * ongoing cytotoxic treatment or radiotherapy for malignant disease * severe chronic cardiac or pulmonary disease (NYHA III and IV) * lifelong anticoagulant treatment * coronary or cerebrovascular incident requiring hospitalization during the last three months * residence abroad * return of unopened letter of invitation and/or reminder, or message of death of the subject (not updated in Population Registry) * failure to provide written informed consent * screening colonoscopy within 10 years

Design outcomes

Primary

MeasureTime frame
Percentage of invitees attending screening colonoscopy in each invitation letter group3 months from the primary assigned screening appointment date

Secondary

MeasureTime frame
Percentage of forms with consent for examination, sent back after invitation letter but before reminding letter. Differences in attendance between men and women depending on type of the invitation.3 weeks after the date of invitation letter

Countries

Poland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026